WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Ozempic sales surge ‘up to 600%’ after Mounjaro price rises

Price hikes are 'kick in the teeth' for patients who will either have to swallow 170 per cent price increase, or switch to 'almost as good' competitor

Raccontata daindependent.co.ukft.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
independent.co.ukStai leggendo10 mesi fa

Ozempic sales surge ‘up to 600%’ after Mounjaro price rises

Price hikes are 'kick in the teeth' for patients who will either have to swallow 170 per cent price increase, or switch to 'almost as good' competitor

originale
ft.com10 mesi fa

Novo Nordisk halves US price of Ozempic

Danish group’s shares rise after it cuts cost for blockbuster diabetes and weight-loss drug for patients without insurance

Leggi questa versione → originale

Timeline cronologica

  1. venerdì 15 agosto 2025·independent.co.uk

    Patients warned not to turn to fake weight loss jabs after UK Mounjaro price hike

    Pharmacists fear rise in sale of dangerous counterfeit medicines as drugmaker triples price of prescription

  2. lunedì 18 agosto 2025·independent.co.uk

    Ozempic sales surge ‘up to 600%’ after Mounjaro price rises

    Price hikes are 'kick in the teeth' for patients who will either have to swallow 170 per cent price increase, or switch to 'almost as good' competitor

  3. lunedì 18 agosto 2025·ft.com

    Novo Nordisk halves US price of Ozempic

    Danish group’s shares rise after it cuts cost for blockbuster diabetes and weight-loss drug for patients without insurance

  4. martedì 19 agosto 2025·independent.co.uk

    Diabetes drug Ozempic will cost half-price for US patients paying cash

    The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes patients